<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02185703</url>
  </required_header>
  <id_info>
    <org_study_id>PM004</org_study_id>
    <nct_id>NCT02185703</nct_id>
  </id_info>
  <brief_title>Chordate System S020 Acute Migraine Clinical Investigation</brief_title>
  <acronym>Amici</acronym>
  <official_title>A Randomized, Placebo-controlled, Double-blind, Multi-center Clinical Investigation to Evaluate the Performance and Safety of the Chordate System When Used in the Treatment of Acute Migraine Attacks of Moderate to Severe Intensity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chordate Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chordate Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of the study is to evaluate the impact of treatment with the Chordate System
      S020 (medical device) on acute migraine headache pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One single migraine attack will be treated either with the Chordate System S020 or with
      Chordate System in placebo mode.

      After a screening visit, up to 3 months before treatment, eligible subjects will be asked to
      return to the center at the onset of their next moderate to severe migraine attack. Subjects
      will be re-checked for eligibility, randomized and treated at the center (treatment visit).
      The subjects will record their response over the next 48 hours using a diary card. A
      follow-up visit will be scheduled 3 to 7 days after the treatment. In addition the subjects
      will be contacted within 24 to 48 hours after treatment initiation via a telephone contact to
      discuss their health including new or ongoing AEs.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Too slow recruitment rate
  </why_stopped>
  <start_date>July 2014</start_date>
  <completion_date type="Actual">July 2015</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Headache relief</measure>
    <time_frame>2 hours after treatment initiation</time_frame>
    <description>Percentage of subjects with a decrease in migraine headache pain from severe or moderate prior treatment to mild or none at 2 hours after treatment initiation with no use of rescue medication during this time period.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain-free rate</measure>
    <time_frame>2 hours after treatment initiation</time_frame>
    <description>Percentage of subjects pain-free (pain intensity rated 'No pain') at 2 hours after treatment initiation with no use of rescue medication.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of recurrence</measure>
    <time_frame>48 hours after treatment initiation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>24 hour sustained pain-free rate</measure>
    <time_frame>24 hours after treatment initiation</time_frame>
    <description>percentage of subjects remaining pain-free</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>48 hour sustained pain-free rate</measure>
    <time_frame>48 hours after treatment initiation</time_frame>
    <description>percentage of subjects remaining pain-free</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to meaningful relief</measure>
    <time_frame>4 hours post-treatment initiation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in nausea, photophobia, phonophobia, vomiting and disability</measure>
    <time_frame>2 hours post-treatment initiation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject global impression</measure>
    <time_frame>48 hours post-treatment initiation.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of rescue medication</measure>
    <time_frame>48 hours post-treatment initiation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency, severity, device-relationship and outcome of all adverse events</measure>
    <time_frame>48 hours post-treatment initiation</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Acute Migraine</condition>
  <arm_group>
    <arm_group_label>Chordate System S020 in treatment mode</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Chordate System S020 in placebo mode</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Chordate System S020 in treatment mode</intervention_name>
    <arm_group_label>Chordate System S020 in treatment mode</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Chordate System S020 in placebo mode</intervention_name>
    <arm_group_label>Chordate System S020 in placebo mode</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects with migraine, with or without aura according to International Headache
             Society (IHS) classification (International Classification of Headache Disorders
             [ICHD]-III beta).

          -  History of 1 to 6 migraine attacks per month for at least 12 previous months.

          -  At least 50% of previous migraine attacks had moderate or severe pain intensity.

          -  History of at least 48 hours of freedom from headache between migraine attacks.

          -  The majority of the previous untreated migraine attacks lasted at least 8 hours.

          -  Migraine onset before the age of 50 years.

        Exclusion Criteria:

          -  History (within one year prior to inclusion into this clinical investigation) of 15 or
             more headache days per month (i.e. headaches of any kind).

          -  More than 6 days per month with non-migraine headaches (within one year prior to
             inclusion into this clinical investigation).

          -  Unable to distinguish between migraine headaches and other headache types at the onset
             of a migraine attack.

          -  Treatment with Botox in the head/neck area within 6 months of the screening visit, or
             between the screening and treatment visit.

          -  Previously treated with an implantable stimulator or any implantable devices in the
             head and/or neck.

          -  Pronounced anterior septal nasal deviation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hans-Christoph Diener, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinikum Essen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universitätsklinikum Tübingen / Zentrum für Neurologie</name>
      <address>
        <city>Tübingen</city>
        <state>Baden-Württemberg</state>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis für Neurologie und Psychiatrie, Psychotherapie, Schmerztherapie</name>
      <address>
        <city>Erding</city>
        <state>Bayern</state>
        <zip>85435</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Neurologie- &amp; Kopfschmerzzentrum</name>
      <address>
        <city>München</city>
        <state>Bayern</state>
        <zip>80802</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Großhadern / Neurologische Klinik der Universität München</name>
      <address>
        <city>München</city>
        <state>Bayern</state>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Migräne-Klinik Königstein</name>
      <address>
        <city>Konigstein im Taunus</city>
        <state>Hessen</state>
        <zip>61462</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Essen / Neurologische Klinik</name>
      <address>
        <city>Essen</city>
        <state>Nordrhein-Westfalen</state>
        <zip>45122</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis für spezielle Schmerztherapie</name>
      <address>
        <city>Wegberg</city>
        <state>Nordrhein-Westfalen</state>
        <zip>41844</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charité - Universitätsmedizin Berlin / Campus Mitte Klinik für Neurologie</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 4, 2014</study_first_submitted>
  <study_first_submitted_qc>July 4, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 9, 2014</study_first_posted>
  <last_update_submitted>August 3, 2015</last_update_submitted>
  <last_update_submitted_qc>August 3, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 5, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

